Cleopatra Hospitals Group S.A.E. (EGX:CLHO)
12.08
-0.03 (-0.25%)
At close: Apr 2, 2026
EGX:CLHO Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 823.88 | 723.35 | 418.18 | 325.76 | 387.25 |
Depreciation & Amortization | 252.74 | 237.24 | 181.28 | 161.15 | 141.91 |
Loss (Gain) From Sale of Assets | -2.37 | -1.91 | 0.32 | 0.43 | 0.79 |
Loss (Gain) From Sale of Investments | 2.44 | 0.01 | 3.29 | -0.25 | -39.92 |
Loss (Gain) on Equity Investments | -10.07 | -4.71 | - | -0.41 | -1.03 |
Stock-Based Compensation | 132 | 71.07 | 22.33 | 16.49 | 8.29 |
Provision & Write-off of Bad Debts | 109.3 | 50.84 | 44.18 | -40.63 | 45.98 |
Other Operating Activities | 389.26 | 410.03 | 120.33 | 36.57 | 47.5 |
Change in Accounts Receivable | -303.99 | -449.12 | -206.39 | -60.25 | 30.92 |
Change in Inventory | 33.77 | -29.65 | -184.15 | -57.04 | 13.95 |
Change in Accounts Payable | 176.28 | 582.56 | 414.07 | 48.62 | -0.35 |
Change in Other Net Operating Assets | 288.67 | -89.7 | -268.14 | 11.37 | 12.88 |
Operating Cash Flow | 1,892 | 1,500 | 557.96 | 439.87 | 648.16 |
Operating Cash Flow Growth | 26.13% | 168.84% | 26.85% | -32.14% | 264.67% |
Capital Expenditures | -2,650 | -2,704 | -825.16 | -424.68 | -282.16 |
Sale of Property, Plant & Equipment | 4.54 | 2.99 | 2.56 | 2.19 | 3.4 |
Investment in Securities | - | - | - | 0.25 | -5.67 |
Other Investing Activities | 46.63 | 35.15 | 25.02 | 37.08 | 50.82 |
Investing Cash Flow | -2,599 | -2,666 | -797.58 | -385.17 | -233.62 |
Short-Term Debt Issued | - | - | - | 183.84 | 60.63 |
Long-Term Debt Issued | 1,264 | 1,672 | 409.43 | 88.03 | - |
Total Debt Issued | 1,264 | 1,672 | 409.43 | 271.87 | 60.63 |
Long-Term Debt Repaid | -85.57 | -65.92 | - | -40.73 | -43.72 |
Total Debt Repaid | -85.57 | -65.92 | - | -40.73 | -43.72 |
Net Debt Issued (Repaid) | 1,179 | 1,607 | 409.43 | 231.14 | 16.9 |
Issuance of Common Stock | - | - | - | 80.7 | - |
Repurchase of Common Stock | -56.41 | -76.45 | -36.45 | -778.27 | -74.18 |
Common Dividends Paid | -146.35 | -113.16 | -64.87 | -67.92 | -47.04 |
Other Financing Activities | -191.73 | -135.8 | -53.45 | -20.44 | -13.22 |
Financing Cash Flow | 784.17 | 1,281 | 254.67 | -554.8 | -117.53 |
Net Cash Flow | 76.77 | 115.33 | 15.05 | -500.09 | 297.01 |
Free Cash Flow | -758.57 | -1,204 | -267.2 | 15.19 | 365.99 |
Free Cash Flow Growth | - | - | - | -95.85% | - |
Free Cash Flow Margin | -10.50% | -22.21% | -7.43% | 0.59% | 14.36% |
Free Cash Flow Per Share | -0.53 | -0.83 | -0.18 | 0.01 | 0.23 |
Cash Interest Paid | 191.73 | 101.04 | 53.45 | 20.44 | 13.22 |
Cash Income Tax Paid | 298.67 | 128.77 | 98.42 | 103.49 | 89.89 |
Levered Free Cash Flow | -729.13 | -1,553 | -447.59 | -62.68 | 178.45 |
Unlevered Free Cash Flow | -588.7 | -1,477 | -404.12 | -40.36 | 199.98 |
Change in Working Capital | 194.72 | 14.09 | -244.61 | -57.29 | 57.4 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.